Shuren: LDT Reliability Critical To Precision Medicine Initiative
This article was originally published in The Pink Sheet Daily
Executive Summary
The head of FDA's device center said the agency's efforts to oversee laboratory developed tests are critical to ensuring reliability of genetic tests in conjunction with the president's Precision Medicine Initiative.